Experience
Represented a leading biotechnology company in appeal of an inter partes reexamination decision.
2013-004840, PTAB, Judges Green, Guest, Lebovitz
Reexamination Control 95/000,440, PTAB
John William Bayer
POSCO
Allergan USA, Inc.; Pierre Fabre Medicament SAS
SAP prevails in first PTAB post-grant review decision
SAP America Inc.
OpenTV, Inc.
OpenTV, Inc.
Henkel Corp.
FIS successfully uses PTAB to invalidate quintessential “Business Method Patents”
Fidelity National Information Services, Inc. (FIS)
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.